The possible discrepancy between previous reports (from cell culture and murine models) and results of our clinical retrospective follow-up study underscores the need to better understand the (substrate) GalCer—(enzyme) Gal3ST1—(product) sulfatide axis in the RCC microenvironment. This evidence concerns the gene GAL3ST1 and renal cell carcinoma.